PUBLISHER: Grand View Research | PRODUCT CODE: 2112285
PUBLISHER: Grand View Research | PRODUCT CODE: 2112285
The global surgical robots market size was valued at USD 14.1 billion in 2025 and is projected to grow from USD 17.2 billion in 2026 to USD 45.6 billion by 2033, at a CAGR of 14.9% from 2026 to 2033. North America dominated the market, accounting for the largest share of 47.0% in 2025. The growth of the industry is driven by the rising adoption of robotic-assisted minimally invasive procedures, the increasing demand for surgical precision, and the growing use of advanced robotic instruments and accessories across hospitals and surgical centers.
Surgical Robots Market Driver Analysis
(1) Expanding Adoption of Robotic-Assisted Minimally Invasive Surgery across Specialties
The surgical robots market is being driven by the growing adoption of robotic-assisted minimally invasive procedures across general surgery, urology, gynecology, orthopedics, thoracic, cardiac, and spine applications. Hospitals are increasingly deploying robotic platforms to improve surgical precision, visualization, instrument control, surgeon ergonomics, and patient recovery outcomes.
The adoption trend is supported by rising procedure volumes and expanding installed bases. In 2025, Intuitive Surgical reported that da Vinci procedures increased by 18% to over 3.1 million globally, including 15% growth in the U.S. and 23% growth internationally. The company also placed 1,721 da Vinci systems during the year and ended 2025 with more than 11,100 da Vinci systems installed globally. In addition, the da Vinci 5 platform recorded strong early adoption, with more than 1,200 systems installed across the U.S., Korea, Japan, and Europe, and over 270,000 procedures performed by year-end 2025
(2) Technological Advancements in Robotic Surgery Platforms
Technological advancements in imaging, navigation, AI-enabled planning, fluorescence imaging, and robotic instrumentation are strengthening the adoption of surgical robots. These innovations help improve intraoperative visualization, procedural accuracy, surgeon control, and workflow efficiency across complex minimally invasive procedures.
Companies are increasingly integrating advanced visualization and decision-support tools into robotic platforms. For instance, in February 2024, CMR Surgical launched vLimeLite, an integrated fluorescence imaging system designed to improve intraoperative visualization using indocyanine green, helping surgeons assess blood flow and tissue perfusion more effectively.
In addition, in February 2026, Medtronic received U.S. FDA clearance for its Stealth AXiS surgical system for spine procedures. The platform integrates surgical planning, real-time navigation, and robotic assistance into a single system and is designed for use across hospitals and ambulatory surgery centers. Such developments indicate a shift toward intelligent, connected robotic platforms that support broader clinical adoption and improve surgical workflow efficiency.
The growing procedural use of robotic platforms further reflects increasing clinical acceptance. In January 2026, the American College of Surgeons reported that more than 12 million surgeries had been performed globally using da Vinci systems, highlighting the expanding role of robotic surgery in improving outcomes, reducing recovery time, and supporting minimally invasive care.
Global Surgical Robots Market Segmentation
This report forecasts revenue & volume growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global surgical robots market report based on component, application, end use, and region: